Qiagen Teams with Max Planck on TB MDx Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen today said that it will collaborate with the Max Planck Institute for Infection Biology's department of immunology to develop a molecular diagnostic test for tuberculosis.

Specifically, the partners will develop a test aimed at assessing the risk of an individual with latent TB developing active TB disease during his lifetime.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.